These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34604435)

  • 1. Amyloidosis: A Rare Cause of Severe Cholestasis and Acute Liver Failure.
    Kim HJ; Tomaszewski M; Lam EC; Xiong W; Moosavi S
    ACG Case Rep J; 2020 Dec; 7(12):e00479. PubMed ID: 34604435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Severe Cholestasis due to Hepatic AL Amyloidosis.
    Dias T; Ferreira D; Moreira H; Nascimento T; Santos A; Carvalho A
    GE Port J Gastroenterol; 2019 Oct; 26(6):425-429. PubMed ID: 31832498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Myeloma Light Chain Amyloidosis Presenting as Hepatic Failure.
    Elgouhari H; Ahmed K; Niazi M; Huntington MK
    S D Med; 2018 Mar; 71(3):112-115. PubMed ID: 29991097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?
    Takao S; Tanaka K; Miyazaki M; Tanaka M; Ohashi T; Kato M; Kotoh K; Aishima S; Takayanagi R
    Clin J Gastroenterol; 2013 Oct; 6(5):386-9. PubMed ID: 26181836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Amyloidosis With Multiorgan Involvement.
    Duve RJ; Moga TG; Yang K; Mahl TC; Dove E
    ACG Case Rep J; 2023 Apr; 10(4):e00999. PubMed ID: 37091204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant hepatomegaly and portal hypertension in an elderly patient with primary liver amyloidosis: an uncommon clinical occurrence.
    Basile G; Villari D; Nicita-Mauro V
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):47-50. PubMed ID: 11409189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary systemic amyloidosis with giant hepatomegaly and portal hypertension: a case report and a review of the literature.
    Serra L; Poppi MC; Criscuolo M; Zandomeneghi R
    Ital J Gastroenterol; 1993 Oct; 25(8):435-8. PubMed ID: 8286779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without obvious liver involvement: unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?].
    Paudice N; Farsetti S; Caroti L; Bandini S; Ciuti G; Tempestini A; Perfetto F; Galli S; Giabbani L; Caldini AL; Bergesio F
    G Ital Nefrol; 2012; 29(1):92-7. PubMed ID: 22388910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course.
    Mainenti PP; Petrelli G; Lamanda R; Amalfi G; Castiglione F
    J Clin Gastroenterol; 1997 Apr; 24(3):173-5. PubMed ID: 9179738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. κ I light chain AL amyloidosis presenting with rapidly progressive renal and hepatic failure with unusual renal amyloid distribution.
    Oe Y; Nakaya I; Yahata M; Murata O; Yaegashi H; Sakuma T; Sato H; Liepnieks JJ; Benson MD; Soma J
    Clin Nephrol; 2012 Jan; 77(1):66-70. PubMed ID: 22185971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloma and severe cholestasis.
    Licht A; Maurer R; Oelz O
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma-associated amyloidosis manifesting as fulminant hepatic failure.
    Ales NC; Daniels JT; Frizell ER; Koff JM; Kaplan KJ; Wortmann GW
    South Med J; 2001 Oct; 94(10):1036-8. PubMed ID: 11702819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic amyloidosis: a prevalence study and clinical characterization of a rare and severe disease.
    Dias E; Cardoso H; Marques M; Liberal R; Lopes S; Pereira P; Santos-Antunes J; Pinheiro J; Lopes J; Carneiro F; Macedo G
    Rev Esp Enferm Dig; 2023 Jan; 115(1):16-21. PubMed ID: 35297258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloidosis: an unusual cause of portal hypertension.
    Takayasu V; Laborda LS; Bernardelli R; Pinesi HT; Silva MP; Chiavelli V; Simões AB; Felipe-Silva A
    Autops Case Rep; 2016; 6(2):9-18. PubMed ID: 27547738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis.
    Norero B; Pérez-Ayuso RM; Duarte I; Ramirez P; Soza A; Arrese M; Benítez C
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):142-9. PubMed ID: 24378278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestasis and renal failure in a patient with secondary amyloidosis.
    Unsal C; Paydaş S; Gönlüşen G
    Ren Fail; 2002 Nov; 24(6):863-6. PubMed ID: 12472208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatomegaly and jaundice as the presenting symptoms of systemic light-chain amyloidosis: A case report.
    Zhang X; Tang F; Gao YY; Song DZ; Liang J
    World J Gastrointest Oncol; 2024 Feb; 16(2):550-556. PubMed ID: 38425387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic amyloidosis in a patient with chronic liver failure: A case report.
    Chen Y; Peng J; Wang Y; Xiao LH; Liu F; Wei YB; Wu XF; Wang LW
    World J Clin Cases; 2024 Jul; 12(19):3918-3924. PubMed ID: 38994313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primarily isolated hepatic involvement of amyloidosis: A case report and overview.
    Ye L; Shi H; Wu HM; Wang FY
    Medicine (Baltimore); 2016 Dec; 95(52):e5645. PubMed ID: 28033255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney and liver involvement in monoclonal light chain disorders.
    Pozzi C; Locatelli F
    Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.